Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Glaucoma in perspective

Lilly drops touted Zyprexa successor for use in schizophrenia

Pomaglumetad methionil disappoints in phase III

UK doctors to be offered ‘highway code’ for social media

RCGP will later this year launch new guidelines to help GPs use sites like Twitter and Facebook appropriately

Novartis building

Novartis on track to file COPD drug in Europe by year-end

Will also file QVA149 in Japan after positive phase III trial results

- PMLiVE

Zaicom appoints John Storey as research director

Joins from YouGov to integrate research efforts with regulatory and marketing teams

- PMLiVE

Roche’s Avastin remains most requested drug in UK’s cancer drugs fund

Accounts for nearly a quarter of all applications

US oncologists least likely to see pharma sales reps

Regulatory constraints, limited time and alternative channels all have effect

Novartis building

Novartis gets EU approval for myelofibrosis drug Jakavi

First alternative to bone marrow or stem cell transplant for rare condition

Cancer Research UK and Channel 4 Announce Fundraising Week

Cancer Research UK and Channel 4 are joining forces to launch ‘Stand Up To Cancer’ in the UK. Television, music and film stars will come together in October in a...

- PMLiVE

AZ’s superbug antibiotic Zinforo cleared by EC

The infections it treats include those caused by the MRSA superbug

- PMLiVE

FDA approves Gilead’s once-daily HIV combination Stribild

US approval for four-in-one drug gives patients simpler treatment option

Ramprasad Reddy to chair Aurobindo’s US business

Will also step down from position as full-time director

- PMLiVE

Laura Patel joins Rock Medical Communications

Takes up role as associate director at UK healthcare comms agency

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links